Study: Bjornsson 2020, Liver International
Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network
Citation
Bjornsson HK, Bjornsson ES, Avula B, Khan IA et al (2020). Liver International. PubMed id 31991029.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Ashwagandha: stress, sleep, thyroid and liver cautions Tier B moderate
B Five adults (mean age 43, three men) with liver injury attributed to ashwagandha supplements, from Iceland and the US Drug-Induced Liver Injury Network (n=5)
Case series with structured expert causality assessment.
All five became jaundiced with nausea, lethargy, itching or abdominal discomfort after 2 to 12 weeks. The injury was cholestatic or mixed. Itching and raised bilirubin lasted 5 to 20 weeks, no one developed liver failure, and liver tests returned to normal within 1 to 5 months in four of the five.
As recorded in this card: Bjornsson HK, Bjornsson ES, Avula B, Khan IA et al (2020), Liver International, [primary]
Note: A harm signal from five cases. It cannot say how often this happens. Not a trial.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.